NFIB and neuroblastoma: Further studies are necessary to investigate the target genes of this repressor activity and to elucidate which of those genes are not repressed in stage 4 NB with LOH at this region and good clinical outcome, as a consequence of the diminished presence of NFI-B3 protein.